基本情報
研究分野
1学歴
2-
- 2006年
-
- 2006年
受賞
2-
2011年
-
2006年
論文
14-
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 25(9) 2023年8月2日AIMS: The relationship between local unipolar voltage (UV) in the pulmonary vein (PV)-ostia and left atrial wall thickness (LAWT) and the utility of these parameters as indices of outcome after atrial fibrillation (AF) ablation remain unclear. METHODS AND RESULTS: Two-hundred seventy-two AF patients who underwent AF ablation were enrolled. Unipolar voltage of PV-ostia was measured using a CARTO system, and LAWT was measured using computed tomography. The primary endpoint was atrial tachyarrhythmia (ATA) recurrence including AF. The ATA recurrence was documented in 74 patients (ATA-Rec group). The UV and LAWT of the bilateral superior PV roof to posterior and around the right-inferior PV in the ATA-Rec group were significantly greater than in patients without ATA recurrence (ATA-Free group) (P < 0.001). The UV had a strong positive correlation with LAWT (R2 = 0.446, P < 0.001). The UV 2.7 mV and the corresponding LAWT 1.6 mm were determined as the cut-off values for ATA recurrence (P < 0.001, respectively). Multisite LA high UV (HUV, ≥4 areas of >2.7 mV) or multisite LA wall thickening (≥5 areas of >1.6 mm), defined as LA hypertrophy (LAH), was related to higher ATA recurrence. Among 92 LAH patients, 66 had HUV (LAH-HUV) and the remaining 26 had low UV (LAH-LUV), characterized by history of non-paroxysmal AF and heart failure, reduced LV ejection fraction, or enlarged LA. In addition, LAH-LUV showed the worst ablation outcome, followed by LAH-HUV and No LAH (log-rank P < 0.001). CONCLUSION: Combining UV and LAWT enables us to stratify recurrence risk and suggest a tailored ablation strategy according to LA tissue properties.
-
Journal of arrhythmia 36(5) 874-882 2020年10月BACKGROUND: To investigate the clinical implication of the temporal difference in atrial fibrillation (AF)-onset in acute decompensated heart failure (ADHF) and its impact on post-discharge prognosis. METHODS: 336 new-onset ADHF patients without any history of AF before admission were enrolled (201 males, 63 ± 16 year-old) and classified into two groups based on their history of AF: the Control group (No AF was detected during hospitalization, n = 278), and the In-hos-AF group (AF occurred during hospitalization, n = 58). Post discharge prognosis including rehospitalization due to worsening HF, cardiac death, all-cause death and cerebrovascular event were compared. RESULTS: Kaplan-Meier analysis demonstrated that the incidence of rehospitalization due to HF, cardiac death, all-cause death and cerebrovascular event in the In-hos-AF group was not significantly different from that in the Control group (P > 0.05 respectively). However, when AF recurred in the In-hos-AF group patients (n = 24, 41%) after discharge, the incidence of rehospitalization due to HF and cardiac deaths were higher than those without AF recurrence (P = 0.018 and P = 0.027 respectively). Cox proportional analysis revealed that AF developing after discharge was proven to be an independent risk factor for rehospitalization due to HF (HR 1.845, P = 0.043), cardiac death (HR 3.562, P = 0.013) and all-cause deaths (HR 2.138, P = 0.020). CONCLUSION: Clinical outcomes of new-onset in-hospital AF patients were as good as those without AF history until AF recurrence. However, AF recurrence led to worse prognosis. Therefore, treatment for new-onset in-hospital AF in ADHF patients might be postponed until AF recurrence.
-
Circulation. Arrhythmia and electrophysiology 13(10) e008602 2020年10月BACKGROUND: The mechanism of esophageal thermal injury (ETI; esophageal mucosal injury and periesophageal nerve injury leading to gastric hypomotility) remains unknown when using a high-power short-duration (HP-SD) setting. This study sought to evaluate the characteristics of esophageal injuries in atrial fibrillation ablation using a HP-SD setting. METHODS: After exclusion of 5 patients with their esophagus at the right portion of left atrium and 21 patients with additional ablations such as box isolation and low voltage area ablation in left atrium posterior wall, 271 consecutive patients (62±10 years, 56 women) who underwent pulmonary vein isolation by radiofrequency catheter ablation were analyzed. In the 101 patients, a HP-SD setting at 45 to 50 W with an Ablation Index module was used (HP-SD group). In the remaining 170 patients before introduction of the HP-SD setting, a conventional power setting of 20 to 30 W with contact force monitoring was used (conventional group). We performed esophagogastroduodenoscopy after pulmonary vein isolation in all patients and investigated the incidence and characteristics of ETI. RESULTS: Although the incidence of ETI was significantly higher in the HP-SD group compared with the conventional group (37% versus 22%, P=0.011), the prevalence of esophageal lesions did not differ between the groups (7% versus 8%). Multivariate logistic regression analysis revealed that the use of the HP-SD setting (odds ratio, 6.09, P<0.001), and the parameters that suggest anatomic proximity surrounding the esophagus, were independent predictors of ETI. However, the majority of ETI in the HP-SD group was gastric hypomotility, and the thermal injury was limited to the shallow layer of the periesophageal wall using the HP-SD setting. CONCLUSIONS: Although the use of the HP-SD setting was a strong predictor of ETI, it could avoid deeper thermal injuries that reach the esophageal mucosal layer.
-
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 25(4) e12749 2020年7月BACKGROUND: Cardiac amyloidosis (CA) is characterized by left ventricular hypertrophy (LVH) and autonomic nervous imbalance due to amyloid infiltration. However, autonomic dysfunction is often seen in heart failure (HF) with LVH from other etiologies. We aimed to characterize autonomic dysfunction in CA from other etiologies of LVH. METHODS: Fifty-five HF patients with LVH (35 males, mean age 65 ± 16 years) were enrolled. LVH was defined as left ventricular mass index measured by echocardiography >95 g/m2 in women and 115 g/m2 in men. The etiology was as follows: amyloid light chain (AL)-CA, n = 14; hypertrophic cardiomyopathy, n = 21; and aortic stenosis (AS), n = 20. With the patient in a clinically stable condition, heart rate variability (HRV) and heart rate turbulence (HRT), which reflect autonomic dysfunction, were measured using Holter monitoring and compared among the three groups. RESULTS: Brain natriuretic peptide levels, LVH severity, left ventricular ejection fraction, and tissue Doppler index E/e' did not differ among the three groups. However, severe abnormalities of HRV and HRT were obtained in AL-CA. In the ROC analysis to identify AL-CA in HF with LVH, the best cutoff value for standard deviation of all R-R intervals, standard deviation of the 5-min mean R-R intervals, turbulence onset, and turbulence slope were 68.5 ms (AUC: 0.865), 58.5 ms (AUC: 0.834), 0.25% (AUC: 0.813), and 1.00 ms/RR (AUC 0.736), respectively. CONCLUSION: Autonomic dysfunction is a hallmark of AL-CA, and its noninvasive assessment by Holter monitoring may be a useful tool for differential diagnosis of HF with LVH.
-
Journal of Interventional Cardiac Electrophysiology 54(2) 101-108 2019年3月 査読有り
MISC
57-
日本循環器学会学術集会抄録集 85回 OJ46-3 2021年3月
-
INTERNATIONAL HEART JOURNAL 56(6) 613-617 2015年11月Several studies have demonstrated that oral intake of n-3 polyunsaturated fatty acids, specifically eicosapentaenoic acid (EPA), prevents ventricular tachyarrhythmias (VT) with ischemic heart disease, but the underlying mechanisms still remain unclear. Thus, we examined the relation between the serum EPA/arachidonic acid (AA) ratio and electrophysiological properties in patients with ischemic heart disease. The study subjects consisted of 57 patients (46 males, mean age, 66 +/- 13 years) with ischemic heart disease. T-wave alternans (TWA) and heart rate variability were assessed by 24-hour Holier ECG, and left ventricular ejection fraction (LVEF) was determined by echocardiography. Fasting blood samples were collected, and the serum EPA/AA ratio was determined. Based on a median value of the serum EPA/AA ratio, all subjects were divided into two groups: serum EPA/AA ratio below 0.33 (Group-L, n = 28) or not (Group-H, n = 29). We compared these parameters between the two groups. LVEF was not different between the two groups. The maximum value of TWA was significantly higher in Group-L than in Group-H (69.5 +/- 22.8 mu V versus 48.7 +/- 12.0 mu V, P = 0.007). In addition, VT defined as above 3 beats was observed in 7 cases (25%) in Group-L, but there were no cases of VT in Group-H (P = 0.004). However, low-frequency (LF) component, high-frequency (HF) component, LF to BF ratio, and standard deviation of all R-R intervals were not different between the two groups. These results suggest that a low EPA/AA ratio may induce cardiac electrical instability, but not autonomic nervous imbalance, associated with VT in patients with ischemic heart disease.
-
INTERNATIONAL HEART JOURNAL 56(6) 613-617 2015年11月Several studies have demonstrated that oral intake of n-3 polyunsaturated fatty acids, specifically eicosapentaenoic acid (EPA), prevents ventricular tachyarrhythmias (VT) with ischemic heart disease, but the underlying mechanisms still remain unclear. Thus, we examined the relation between the serum EPA/arachidonic acid (AA) ratio and electrophysiological properties in patients with ischemic heart disease. The study subjects consisted of 57 patients (46 males, mean age, 66 +/- 13 years) with ischemic heart disease. T-wave alternans (TWA) and heart rate variability were assessed by 24-hour Holier ECG, and left ventricular ejection fraction (LVEF) was determined by echocardiography. Fasting blood samples were collected, and the serum EPA/AA ratio was determined. Based on a median value of the serum EPA/AA ratio, all subjects were divided into two groups: serum EPA/AA ratio below 0.33 (Group-L, n = 28) or not (Group-H, n = 29). We compared these parameters between the two groups. LVEF was not different between the two groups. The maximum value of TWA was significantly higher in Group-L than in Group-H (69.5 +/- 22.8 mu V versus 48.7 +/- 12.0 mu V, P = 0.007). In addition, VT defined as above 3 beats was observed in 7 cases (25%) in Group-L, but there were no cases of VT in Group-H (P = 0.004). However, low-frequency (LF) component, high-frequency (HF) component, LF to BF ratio, and standard deviation of all R-R intervals were not different between the two groups. These results suggest that a low EPA/AA ratio may induce cardiac electrical instability, but not autonomic nervous imbalance, associated with VT in patients with ischemic heart disease.
講演・口頭発表等
150-
Congress of the European Society of Cardiology 2012 2012年
-
Congress of the European Society of Cardiology 2012 2012年
-
The 76th Annual Scientific Meeting of the Japanese Circulation Society 2012年
-
The 76th Annual Scientific Meeting of the Japanese Circulation Society 2012年
-
The 76th Annual Scientific Meeting of the Japanese Circulation Society 2012年
-
The 76th Annual Scientific Meeting of the Japanese Circulation Society 2012年
-
The 76th Annual Scientific Meeting of the Japanese Circulation Society 2012年
-
Heart Rhythm 2012, 33rd Annual Scientific Sessions 2012年
-
Congress of the European Society of Cardiology 2012 2012年
-
Congress of the European Society of Cardiology 2012 2012年
-
Congress of the European Society of Cardiology 2012 2012年
-
Heart Rhythm 2011, 32nd Annual Scientific Sessions 2011年
-
Heart Rhythm 2011, 32nd Annual Scientific Sessions 2011年
-
第20回 日本心血管インターベンション治療学会 2011年
-
The 4th Asia Pacific Heart Rhythm Society(APHRS) Scientific Session, 第26回 日本不整脈学会,第28 回 日本心電学会, 合同学術集会 2011年
-
The 4th Asia Pacific Heart Rhythm Society(APHRS) Scientific Session, 第26回 日本不整脈学会,第28 回 日本心電学会, 合同学術集会 2011年
-
The 4th Asia Pacific Heart Rhythm Society(APHRS) Scientific Session, 第26回 日本不整脈学会,第28 回 日本心電学会, 合同学術集会 2011年
-
The 4th Asia Pacific Heart Rhythm Society(APHRS) Scientific Session, 第26回 日本不整脈学会,第28 回 日本心電学会, 合同学術集会 2011年
-
Scientific Sessions of American Heart Association 2011 2011年
-
Heart Rhythm 2011, 32nd Annual Scientific Sessions 2011年
-
Heart Rhythm 2011, 32nd Annual Scientific Sessions 2011年
-
The 75th Annual Scientific Meeting of the Japanese Circulation Society 2011年
-
The 75th Annual Scientific Meeting of the Japanese Circulation Society 2011年
-
The 75th Annual Scientific Meeting of the Japanese Circulation Society 2011年
-
The 75th Annual Scientific Meeting of the Japanese Circulation Society 2011年
-
The 75th Annual Scientific Meeting of the Japanese Circulation Society 2011年
-
The 75th Annual Scientific Meeting of the Japanese Circulation Society 2011年
-
The 4th Asia Pacific Heart Rhythm Society(APHRS) Scientific Session, 第26回 日本不整脈学会,第28 回 日本心電学会, 合同学術集会 2011年
-
The 4th Asia Pacific Heart Rhythm Society(APHRS) Scientific Session, 第26回 日本不整脈学会,第28 回 日本心電学会, 合同学術集会 2011年
-
The 4th Asia Pacific Heart Rhythm Society(APHRS) Scientific Session, 第26回 日本不整脈学会,第28 回 日本心電学会, 合同学術集会 2011年
-
The 4th Asia Pacific Heart Rhythm Society(APHRS) Scientific Session, 第26回 日本不整脈学会,第28 回 日本心電学会, 合同学術集会 2011年
-
Scientific Sessions of American Heart Association 2011 2011年
Works(作品等)
1共同研究・競争的資金等の研究課題
1-
日本学術振興会 科学研究費助成事業 2012年4月 - 2013年3月